Senate Subcommittee Hearing on Energy Legislation (Nov 6, 2019)
January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing serves as a formal legislative step to review and gather expert testimony on 12 energy bills, which could influence future federal energy policy, research funding, and regulatory standards.
Potentially affected actors named in the source documents. Mention is not a position.
Energy Industry Organizations
Various trade associations and energy companies submitted testimony or letters for the record regarding pending legislation.
U.S. Department of Energy
The Department provided official testimony and responses to questions regarding the proposed energy legislation.
Last recorded activity January 1, 2021.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on November 6, 2019, in the Dirksen Senate Office Building.
- The Subcommittee reviewed 12 specific bills: S. 876, S. 1890, S. 2425, S. 2508, S. 2556, S. 2657, S. 2660, S. 2668, S. 2688, S. 2702, S. 2714, and S. 2714.
- Daniel Simmons, Assistant Secretary of the Office of Energy Efficiency and Renewable Energy (EERE), provided testimony.
- The hearing included opening statements from Senators Bill Cassidy, Martin Heinrich, Angus S. King, Jr., Lisa Murkowski, and Catherine Cortez Masto.
- Numerous organizations submitted letters for the record, including the American Wind Energy Association, the U.S. Green Building Council, and the Electric Power Supply Association.
Frequently Asked Questions
What was the purpose of this hearing?
Where can I read the text of the bills discussed?
Why It Matters
The hearing serves as a formal legislative step to review and gather expert testimony on 12 energy bills, which could influence future federal energy policy, research funding, and regulatory standards.
News Coverage
Lobbying Activity
340B Health
2026
“The SECURE 340B Act (H.R. 9599); The Tax-Exempt Hospital Transparency Act (H.R.9504); 340B PATIENTS Act (H.R. 4581/S.2372); Community Health Center Drug Pricing Protection Act (H.R. 7391); 2027 OPPS Proposed Rule; Information Collection Request Title: 340B Rebate Model Pilot Program Application, Implementation, and Evaluation, OMB Number 0906-NEW; Manufacturer Demand for Access to in-House Pharmacy Claims Data; Lilly 340B Drug Pricing Denial; HRSA Rebate Model Pilot pending regulation; Pending Senate "Gang of Six" draft 340B legislation; FY27 Appropriations legislation; Pending introduction of updated and expanded Community Health Center Drug Pricing Protection Act.”
SLOAT HIGGINS JENSENAND ASSOCIATES
on behalf of AMERICAN INTERNATIONAL GROUP
ROSE & KINDEL
on behalf of GLOBAL PHOTON SYSTEMS INC. & ITS SUBSIDIARIES
LAWRENCE J SUFFREDIN
on behalf of AMAZON
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
BRIDGET M O'KEEFE
on behalf of NEW YORK PRIVATE RESIDENCES CONDOMINIUM ASSOCIATION
PAT DOERR
on behalf of HOSPITALITY BUSINESS ASSOC OF CHICAGO
BRIDGET M O'KEEFE
on behalf of SUSAN WHITING
JEFFREY A GLASS
on behalf of CITIZENS UTILITY BOARD
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Extensive Stakeholder Participation
The hearing record includes a high volume of formal letters from diverse energy sector organizations, indicating significant industry interest in the 12 bills being reviewed.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools